GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Valuation Rank

TRUMY (Terumo) Valuation Rank


View and export this data going back to 2008. Start your Free Trial

What is Terumo Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Terumo Valuation Rank Related Terms

Thank you for viewing the detailed overview of Terumo's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Terumo Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Valuation Rank
Comparable Companies
TSE:7741 TSE:7747 TSE:8086 TSE:3360 TSE:7716 TSE:3046 TSE:7817 TSE:7730 TSE:3593 TSE:7780 ISRG XPAR:EL BDX XSWX:ALC RMD OCSE:COLO B XSWX:STMN XPAR:DIM BAX COO
Traded in Other Exchanges
TRUMF:USA 4543:Japan TUO0:Germany
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Website
https://www.terumo.com
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2024, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 36% of Terumo's revenue.